ReviewCancer immunology, immunotherapy : CII2021

Tuberculosis following programmed cell death receptor-1 (PD-1) inhibitor in a patient with non-small cell lung cancer. Case report and literature review.

Aasir M Suliman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.